How Is The Lower Respiratory Tract Therapeutics Market Expected To Grow At 8.2% CAGR Over 2025–2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Lower Respiratory Tract Therapeutics Market Expected To Grow In Terms Of Size?
The market for therapeutics for the lower respiratory tract has seen significant growth in recent years. From $36.03 billion in 2024, it is predicted to expand to $38.84 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.8%. The rise during the historical period is linked to the discovery of new antibiotics, vaccination schemes, anti-smoking initiatives, progress in inhalation therapy, and the development of healthcare infrastructure.
In the forthcoming years, a significant increase is anticipated in the size of the lower respiratory tract therapeutics market, which is hoped to reach a valuation of $53.25 billion by 2029. This growth, which implies an 8.2% compound annual growth rate (CAGR), is largely due to factors such as escalating levels of air pollution, an aging demographic, resistance to antimicrobials, and other environmental issues. Other notable trends for this period consist of precision medical treatments, technological advancements, biologic therapy procedures, use of telehealth in respiratory care, and personalised inhalation devices.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12591&type=smp
What Are The Primary Factors Supporting The Lower Respiratory Tract Therapeutics Market Expansion?
The increasing incidence of respiratory ailments is projected to propel the lower respiratory tract therapeutics market. These ailments pertain to the health conditions affecting the respiratory system, encompassing the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. Lower respiratory tract therapeutics play a crucial role in early detection and diagnosis of these conditions, paving the way for efficient treatment and management, thereby preventing the disease’s growth. Such measures are integral to preventing the spread of infectious respiratory ailments and mitigating the risk of complications. For example, as per NCD Alliance data in September 2022, a Switzerland-based civil society group, lung cancer had been the topmost cause of cancer-related deaths globally, anticipating 2.2 million new cases and 1.8 million deaths year after year. Additionally, chronic respiratory illnesses affected 550 million adults worldwide, leading to the death of 4.2 million people or 7%. Hence, the escalating occurrence of respiratory conditions is likely to stimulate the lower respiratory tract therapeutics market.
Which Segmentation Categories Are Highlighted In The Lower Respiratory Tract Therapeutics Market Analysis?
The lower respiratory tract therapeuticsmarket covered in this report is segmented –
1) By Disease Type: Asthma; Chronic Obstructive Pulmonary Disease; Pneumonia; Tuberculosis; Bronchitis; Other Diseases
2) By Drug Class: Antibiotics; Non-Steroidal Anti-Inflammatory Drug; Cough Suppressant; Nasal Decongestant; Other Drug Classes
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Asthma: Allergic Asthma; Non-allergic Asthma
2) By Chronic Obstructive Pulmonary Disease (COPD): Chronic Bronchitis; Emphysema
3) By Pneumonia: Bacterial Pneumonia; Viral Pneumonia
4) By Tuberculosis: Drug-sensitive Tuberculosis; Drug-resistant Tuberculosis
5) By Bronchitis: Acute Bronchitis; Chronic Bronchitis
6) By Other Diseases: Interstitial Lung Disease; Cystic Fibrosis; Pulmonary Hypertension
Which Trends Are Likely To Redefine Growth Paths In The Lower Respiratory Tract Therapeutics Market?
A prominent trend in the lower respiratory tract therapeutics market is the introduction of innovative products. The major players in this market are bringing new products to cement their position. For example, AstraZeneca PLC, a British pharmaceutical and biotech company, and Sanofi S.A., a French pharmaceutical company, launched Beyfortus in November 2022. This medication, designed to prevent lower respiratory tract disease in newborns and infants, has gained approval from the European Union (E.U). It aims to prevent respiratory syncytial virus (RSV) and lower respiratory tract disease in newborns and infants during the initial RSV season. Remarkably, it’s the first single-dose RSV passive vaccination available for all newborns, whether healthy, born at term or prematurely, or with particular health problems.
Which Organizations Are At The Forefront Of The Lower Respiratory Tract Therapeutics Market?
Major companies operating in the lower respiratory tract therapeutics market include Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Vertex Pharmaceuticals Incorporated, Grifols S.A., Menarini Group, Chiesi Farmaceutici S.p.A., Cipla Limited, Mundipharma International Limited, Orion Corporation, Sunovion Pharmaceuticals Inc., Innoviva Inc., Insmed Incorporated, Vectura Group plc, Theravance Biopharma Inc., Verona Pharma plc, Circassia Pharmaceuticals plc
Access The Complete Report Here:
Which Geographic Regions Are Creating Strong Demand In The Lower Respiratory Tract Therapeutics Market?
North America was the largest region in the lower respiratory tract therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lower respiratory tract therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=12591&type=smp
Browse Through More Reports Similar to the Global Lower Respiratory Tract Therapeutics Market 2025, By The Business Research Company
Respiratory Disease Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report
Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2025
Respiratory Devices And Equipment Therapeutic Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
